Delisting risk
CytoSorbents (CTSO)
Develops blood-purification cartridges for critical care and cardiac surgery, commercializing CytoSorb internationally.
$0.3499
Pre-market−0.04 (−9.26%)
At close$0.3856(+14.08%)
Something off on this page? Send us feedback.
Next report
Nov 12, 2026
estimated · in 70 days
EPS estimate
−$0.05
Revenue estimate
$9.9M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.03−$0.06−$0.05−$0.04−$0.09−$0.08−$0.07Pending
Estimate−$0.07−$0.08−$0.07−$0.06−$0.05−$0.06−$0.04−$0.05
Surprise+57.1%+25.0%+28.6%+33.3%−80.0%−33.3%−75.0%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$6.5M$8.7M$9.6M$9.5M$9.2M$8.9M$9.6MPending
Estimate$10.1M$9.0M$9.2M$9.2M$9.8M$9.4M$9.4M$9.9M
Surprise−35.3%−3.1%+4.3%+2.9%−5.6%−5.7%+2.6%—
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.05 | — | — |
| Aug 2026 | −$0.04 | −$0.07 | −75.0% |
| May 2026 | −$0.06 | −$0.08 | −33.3% |
| Mar 2026 | −$0.05 | −$0.09 | −80.0% |
| Nov 2025 | −$0.06 | −$0.04 | +33.3% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | −$0.05 | — | — | $9.9M | — | — | — |
| Aug 6, 2026 | −$0.04 | −$0.07 | −75.0% | $9.4M | $9.6M | +2.6% | −9.7% |
| May 13, 2026 | −$0.06 | −$0.08 | −33.3% | $9.4M | $8.9M | −5.7% | −5.1% |
| Mar 25, 2026 | −$0.05 | −$0.09 | −80.0% | $9.8M | $9.2M | −5.6% | −10.6% |
| Nov 13, 2025 | −$0.06 | −$0.04 | +33.3% | $9.2M | $9.5M | +2.9% | −0.8% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| Aug 7, 2025 | |||||||
| May 14, 2025 | |||||||
| Mar 31, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 13, 2024 | |||||||
| May 9, 2024 | |||||||
| Mar 14, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 1, 2023 | |||||||
| May 2, 2023 | |||||||
| Mar 9, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 2, 2022 | |||||||
| May 3, 2022 | |||||||
| Mar 8, 2022 | |||||||
| Nov 4, 2021 | |||||||
| Aug 3, 2021 | |||||||
| May 4, 2021 | |||||||
| Mar 9, 2021 | |||||||
| Nov 4, 2020 | |||||||
| Aug 4, 2020 | |||||||
| May 5, 2020 | |||||||
| Mar 5, 2020 | |||||||
| Nov 5, 2019 | |||||||
| Aug 6, 2019 | |||||||
| May 7, 2019 | |||||||
| Mar 7, 2019 | |||||||
| Nov 6, 2018 | |||||||
| Aug 2, 2018 | |||||||
| May 8, 2018 | |||||||
| Mar 8, 2018 | |||||||
| Nov 9, 2017 | |||||||
| Aug 7, 2017 | |||||||
| May 8, 2017 | |||||||
| Mar 3, 2017 | |||||||
| Nov 7, 2016 | |||||||
| Aug 9, 2016 | |||||||
| May 9, 2016 | |||||||
| Mar 9, 2016 | |||||||
| Nov 13, 2015 | |||||||
| Aug 13, 2015 | |||||||